Investment Q&A

Q: Hi Peter & team: Re your answer to Peter yesterday, "Over a long period, sector allocation is in fact more important than stock selection." Please let me know what sector allocation should be, or reasonable.

Thank you and keep up with your great work!

Q: Can you explain the recent run ups on the stocks Organigram and Aphria? Are they just paralleling the excitement generated by Canopy moving from the Venture Exchange to the TSX? I feel like I might be missing the boat if I don't buy now.

Q: Gentlemen


I am a new subscriber. I like your portfolios but I would like to ask do you update these portfolios during the month as you see changes that need to be made based on new information or do you just update at the end of every month.

Thanks

Wayne

Q: Hello Team 5i, I know this is a High Risk ETF, but this the start of the Seasonal Upleg for Gold. Not without volatility, but worth applying a 2.5% of my Portfolio Value? I suspect the Upside is greater than the Downside. As always, I value your thoughts!

Thanks. Austin

Q: Gentlemen

I am looking for a company to fill out my Real Estate space in my portfolio. Which of the above do you favour?

I am a conservative investor and with a good quality company be willing to hold for the long term.

Thanks

Q: Any thoughts on McCoy? Liked this company before the oil meltdown but they are really suffering these days. Still with negative EBITDA and their press release says they need an upswing in activity to go positive. I'm holding a few shares. Wondering whether to dump them and move on or ride through this cycle.

Q: What do you think of this company which is a supplier of powertrain systems to most car companies. It seems to be a very stable company with a decent moat.

The only 2 things I can see is the vehicle market is slowing and their dept more than doubled over the past year (I think they issued notes recently).

Thank You,
Andrew

Q: Hi Folks:
What do you think of Osisko's results for the quarter?

Q: What are your top recommendations for Canadian power producers. I am selling Northland Power (NPI) based on my advisor's recommendation and would like to re-invest in the same sector.

Q: Could you comment why Kirkland Lake Gold (KGI) is lagging other similar gold miners
like Detour Gold(DGC),Richmont Mines(RIC) and Newmarket Mines(NMI)?
These companies seem to be outperforming Kirkland Lake.
Thanks for your help.
Oleh Korol

Q: Please comment on ZCL latest earning release. Thanks

Q: I know it is way to small for you guys, but is it possible to get an opinion about future potential for EUO Eurocontrol.
One of the largest players in that sector SICPA now owns 12.4%. They are doing a share buy back up to 10% of the companies estimated public float , and insiders have decent positions

Thanks,
David

Q: Hello 5i team
I was curious if you thought that the move on Bristol Myers was over done and that this may be a opportunity to buy in?

Q: Hi, Could you comment on Tourmaline's recent earnings, and would you feel comfortable buying a full position into this momentum?

Q: I have noted that this company's stock has fallen lately. I would like your opinion

Q: INE just released its Q2 results, earnings are up but cash flow is down and the dividend payout ratio is up as a result. So is the dividend at current level sustainable? And what is your take overall of the Q2 results.

Thanks.

Q: There has been a sharp sell-off in this stock since Jul 28 when they announced latest results. Were the figures that bad?
Thanks

Q: I am currently hold Cervus in my TFSA at a large loss. Would a switch to New Flyer make sense at this point?

Q: A year ago, Knight signed a deal to distribute 3 of Advaxis's products in Canada and bought about 400,000 shares at $13.91, a premium at the time from the Advaxis treasury. The shares tanked to $5, recovered to $8 and have jumped %6 to $14 in the past 3 days on the announcement that Amgen bought worldwide rights to another Advaxis drug and gave them $40 Million. This will help Knight as the shares appreciate but will it hurt their deal on the other 3 drugs they represent as Advaxis may concentrate on the behemoth deal with a super-large pharma co. and neglect their other products.
Knight's share price has help up well during the healthcare decline. Do you think they will one day do a big deal or continue to drip out their $600M in miniscule does? I am sure this company will be a blockbuster some day, but I may not live long enough to see it!
Thanks.

Q: Hi 5i - of all of the growth stocks you're watching (in portfolio or not), what would be your top three today in terms of an attractive valuation and 3 year growth potential? (I know you must love these questions :))